MAZ-Mediated Ubiquitin-Conjugating Enzyme E2C Upregulation Promotes Breast Cancer Progression via the MAPK Signaling Pathway

Researchers highlighted the critical role of the MAZ/UBE2C/MAPK signaling axis in the progression of breast cancer and identify potential novel therapeutic targets for its treatment.